cp wire

CP Wire Articles

Virtually everyone has heard recent discussions about the microbiome and its effect on human health. It... read more
Mon, 05/21/18 - 04:47 pm
admin

Cosmo Pharmaceuticals N.V. (SIX: COPN) announced on 5/21/18 that the U.S. Food and Drug Administration (FDA) has set a PDUFA date of November 16, 2018 for its decision on the New Drug Application... read more

Mon, 05/21/18 - 12:56 pm
CP Staff



ViiV Healthcare, announced on 5/21/18  that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human... read more

Mon, 05/21/18 - 08:30 am
CP Staff

PROCEPT BioRobotics, a Silicon Valley robotics company developing intelligent surgical solutions to transform the field of urology, has announced early data from the global Phase III WATER II (... read more

Mon, 05/21/18 - 08:21 am
CP Staff

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced on 5/18/18 a poster presentation of additional prostate cancer data (Abstract #229675) at the American Society of Clinical Oncology (ASCO)... read more

Fri, 05/18/18 - 09:35 am
CP Staff

Accent Therapeutics, a biopharmaceutical company developing breakthrough treatments for cancer patients, today announced $40 million in Series A capital to establish a discovery platform and... read more

Fri, 05/18/18 - 09:24 am
CP Staff

BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of... read more

Thu, 05/17/18 - 09:53 am
CP Staff

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology, and its research collaborator, Ospedale San... read more

Thu, 05/17/18 - 09:35 am
CP Staff

  • Exelixis will receive a milestone payment of $50 million
  • Approval based on Cabometyx vs versus sunitinib in CABOSUN trial
  • Cabometyx was approved for reimbursement in... read more
Thu, 05/17/18 - 09:17 am
CP Staff

Pfizer Inc. (NYSE: PFE) announced on 5/17/18 positive top-line results of a Phase 3 study examining the use of Lyrica (pregabalin) Oral Solution CV as adjunctive therapy for partial onset seizures... read more

Thu, 05/17/18 - 09:00 am
CP Staff

Turnstone Biologics  announced on 5/16/18 it has received U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug Application (IND) for MG1-HPV for the treatment of... read more

Wed, 05/16/18 - 08:28 am
CP Staff

BioLineRx Ltd. (NASDAQ: BLRX)(TASE: BLRX), announced on 5/16/18 that the European Patent Office (EPO) has issued a Decision to Grant a patent claiming the use of BL-8040 with cytarabine, a... read more

Wed, 05/16/18 - 08:25 am
CP Staff


EIP Pharma, announced  on 5/16/18 the successful completion of a $20.5 million Series B financing. The Series B financing was led by Access Industries. This new round follows a Series A... read more

Wed, 05/16/18 - 07:55 am
CP Staff

Indivior PLC (LON: INDV) Indivior announced on 5/15/18 that its U.S. subsidiary, Indivior Inc., together with Aquestive Therapeutics, Inc. (formerly known as Monosol Rx, LLC), entered into a... read more

Tue, 05/15/18 - 09:36 am
CP Staff

UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercializing antibiotics in the US, announced on 5/15/18 the signature of an exclusive... read more

Tue, 05/15/18 - 09:18 am
CP Staff

Celsius Therapeutics, launched on 5/15/18 with a $65 million Series A financing led by Third Rock Ventures with participation from GV (formerly Google Ventures), Heritage Provider Network, Casdin... read more

Tue, 05/15/18 - 09:08 am
CP Staff

Intellia Therapeutics, Inc. (NASDAQ:NTLA),  announced on 5/14/18 the addition of new scientific advisors in immuno-oncology and autoimmunity. The advisors hail from prestigious international... read more

Mon, 05/14/18 - 10:03 am
CP Staff

Beam Therapeutics announced today that it is launching to develop precision genetic medicines that make edits to individual base pairs in the genetic code. Co-founded by scientific pioneers known... read more

Mon, 05/14/18 - 09:14 am
CP Staff

UCB announced on 5/14/18 that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the company's newest anti-epileptic drug (AED) Briviact (... read more

Mon, 05/14/18 - 08:57 am
CP Staff

Synaffix B.V. announced today the expansion of its Scientific Advisory Board (SAB) with the addition of Dr. John M. Lambert, the former Chief Scientific Officer of ImmunoGen, Inc.

Dr.... read more

Mon, 05/14/18 - 08:43 am
CP Staff

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.